Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

M. Uchida, T. Nakamura, Y. Makihara, K. Suetsugu, H. Ikesue, Y. Mori, K. Kato, M. Shiratsuchi, K. Hosohata, T. Miyamoto, K. Akashi

研究成果: Contribution to journalArticle査読

1 被引用数 (Scopus)

抄録

The antiemetic effects and safety of granisetron and palonosetron against chemotherapy-induced nausea and vomiting (CINV) were retrospectively evaluated in patients with non-Hodgkin lymphoma receiving bendamustine-based chemotherapy. A total of 61 patients were eligible for this study. Before starting the bendamustine-based chemotherapy, granisetron or palonosetron were intravenously administered with or without aprepitant and/or dexamethasone. The proportions of patients with complete control (CC) during the overall (during the 6 days after the start of the chemotherapy), acute (up to 2 days), and delayed (3 to 6 days) phases were assessed. CC was defined as complete response with only grade 0–1 nausea, no vomiting, and no use of antiemetic rescue medication. Granisetron or palonosetron alone were administered to 9 and 19 patients, respectively. Aprepitant and/or dexamethasone were combined with granisetron and palonosetron in 28 and 5 patients, respectively. Acute CINV was completely controlled in all patients. Both granisetron monotherapy and palonosetron combination therapy could provide good control of delayed CINV, although the CC rates during the delayed and overall phases were not significantly different among mono- and combination therapy of the antiemetics. There was no significant difference in the frequencies of adverse drug events between the granisetron and palonosetron treatment groups. The present study showed that the antiemetic efficacy and safety of granisetron-based therapy were non-inferior to those of palonosetron-based therapy. Taken together with treatment costs, granisetron monotherapy would be adequate to prevent CINV in patients with non-Hodgkin lymphoma receiving bendamustine-based chemotherapy.

本文言語英語
ページ(範囲)304-308
ページ数5
ジャーナルPharmazie
73
5
DOI
出版ステータス出版済み - 2018

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

フィンガープリント 「Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル